Skip to main content
v2026.11,986 entries · CC-BY 4.0

Addiction Journal: Scope, Metrics, and Submission Guide

Explore Addiction journal: aims, scope, Wiley hybrid open access, ScholarOne submission workflows, ISAJE ethics, and peer review standards in neuroscience.

Written and maintained by CASRAI Editorial Board

Published

On this page

The Addiction journal is a monthly, peer-reviewed scientific publication published by John Wiley and Sons on behalf of the Society for the Study of Addiction (SSA), serving as the premier international research forum for empirical, epidemiological, human experimental, clinical, and policy investigations into psychoactive substance use and addictive behaviors.

For research teams, clinical investigators, and academic institutions, navigating the journal requires understanding its hybrid open-access publishing models, funder compliance requirements, and editorial workflows within scholarly publishing. Authors assessing prospective venues often evaluate related publications such as the International Journal of Drug Policy and Substance Use and Misuse alongside publisher governance at Wiley and persistent identifier tracking through Crossref DOIs.

What it is

The Addiction journal is an international, peer-reviewed journal dedicated to advancing scientific knowledge regarding behavioral dependencies and substance-related disorders. Formally established under its modern title in 1993, the journal is cataloged in biomedical and scientific registries under Print ISSN 0965-2140 and Electronic ISSN 1360-0443, with National Library of Medicine (NLM) Unique ID 9304118 and title abbreviation Addiction.

The publication has an extensive historical lineage reflecting the evolution of medical and scientific understanding of dependence. Originating in the United Kingdom in 1884 as the Proceedings of the Society for the Study and Cure of Inebriety, the publication was renamed the British Journal of Inebriety in 1903. In 1947, the title was modernized to the British Journal of Addiction to Alcohol and other Drugs, reflecting a broader scientific interest in pharmacological agents beyond alcohol. In 1993, Volume 88 adopted the singular title Addiction to symbolize an international, multidisciplinary scope encompassing all chemical dependencies and behavioral addictions.

Bibliographically, Addiction is indexed across all major scientific databases, including MEDLINE, PubMed, Clarivate Social Sciences Citation Index (SSCI), Science Citation Index Expanded (SCIE), Scopus, PsycINFO, and Embase. Within the Medical Subject Headings (MeSH) taxonomy, the journal is categorized primarily under “Substance-Related Disorders” and “Tobacco Use Disorder”. The journal has consistently occupied top-tier rankings in the Journal Citation Reports categories for Substance Abuse, Psychiatry, and Psychology.

Beyond publishing peer-reviewed empirical papers, the journal acts as a key communicative bridge connecting scientific researchers, clinicians, healthcare practitioners, and government policymakers. Its commentaries, commissioned debates, and methodological guidelines frequently shape public health regulations, World Health Organization guidance documents, and clinical practice frameworks internationally. As detailed in the comparative data table below, Addiction maintains high bibliographic standards and strict editorial oversight alongside its peer publications in substance science.

Who runs it and what it covers

The journal is wholly owned by the Society for the Study of Addiction (SSA), an independent scientific society established in London in 1884. The SSA provides institutional governance and oversees the journal’s strategic direction, while commercial production, distribution, digital hosting, and subscription licensing are managed under a long-term partnership with John Wiley and Sons.

Editorial operations are directed by Editor-in-Chief John Marsden, Professor of Addiction Psychology at King’s College London, alongside Deputy Editor-in-Chief Keith Humphreys, Esther Ting Memorial Professor at Stanford University. Editorial management is organized across dedicated regional offices to ensure balanced international representation:

  • The Americas: Led by Regional Editor Christina Andrews, managing submissions originating across North, Central, and South America.
  • Africa, Asia, and Europe: Led by Regional Editors Jamie Brown and Janna Cousijn, overseeing epidemiological, clinical, and policy manuscripts across the Eastern Hemisphere.
  • Australia, New Zealand, and Southeast Asia: Led by Regional Editor Shane Darke, coordinating scholarly review across Australasia.

The journal’s editorial structure also incorporates specialized Senior Editors, Associate Editors, and a dedicated team of Statistical and Methodology Review Editors. These methodological editors conduct independent assessments of statistical modeling, psychometric validation, and data transparency before final acceptance.

The substantive scope of Addiction encompasses pharmacological substances and behavioral dependencies across six primary thematic areas:

  • Alcohol and Liver Health: Epidemiological surveys, clinical trials of pharmacotherapies, screening instruments, brief interventions, and population-level taxation or pricing policies.
  • Tobacco and Nicotine Science: Smoking cessation clinical trials, epidemiological surveillance of combustible tobacco, behavioral impacts of electronic nicotine delivery systems (ENDS), and tobacco control regulatory evaluation.
  • Illicit and Controlled Substances: Opioid agonist maintenance therapy, overdose prevention, stimulant dependence interventions, cannabis legalization impacts, and novel psychoactive substances (NPS).
  • Prescription Drug Misuse: Non-medical use of analgesics, benzodiazepines, and prescription stimulants, including electronic prescription monitoring program evaluations.
  • Behavioral Addictions: Empirical investigations into gambling disorder, problematic gaming, and emerging non-substance behavioral dependencies.
  • Health Economics and Policy Evaluation: Cost-effectiveness analyses of treatment interventions, minimum unit pricing models, marketing restrictions, and international drug treaty compliance.

The journal enforces clear scope boundaries. Purely preclinical animal studies without immediate translational application to human behavior or clinical practice are outside its primary focus and are typically redirected to specialized neurobiological journals such as Addiction Biology. Similarly, routine general psychiatric studies lacking a primary addiction component or unvalidated qualitative case reports are deemed out of scope.

A central pillar of the journal’s governance is its adherence to the ethical standards established by the International Society of Addiction Journal Editors (ISAJE). Addiction was a founding signatory of the landmark 1997 Farmington Consensus. Consequently, the journal enforces strict conflict-of-interest transparency, requires pre-registration of clinical trials on public registries such as ClinicalTrials.gov, and maintains a strict policy refusing to consider or publish research funded in whole or in part by the tobacco or vaping industries.

How to search or use it

For researchers, clinicians, and scholarly authors preparing manuscripts for Addiction, navigating the journal involves interacting with Wiley Online Library for content retrieval and ScholarOne Manuscripts for editorial submission. The workflow encompasses seven structured stages:

  1. Pre-Submission Scoping and Article Type Selection: Authors must determine the appropriate manuscript format. The core format is the Research Report, which has a strict word limit of under 3,500 words (excluding abstract, tables, figures, and references). Other recognized article types include Reviews (systematic reviews, meta-analyses, and narrative syntheses under 5,000 words), Short Reports (concise empirical briefs under 2,000 words), Commentaries (invited or unsolicited analytical essays under 1,500 words), and Letters to the Editor (targeted critical discussions under 800 words).
  2. Structuring the Manuscript and Abstract: Submissions must follow uniform structural conventions. Research Reports require a structured abstract of no more than 300 words organized into seven explicit headings: Background and Aims, Design, Setting, Participants, Measurements, Findings, and Conclusions. Main texts must follow the standard IMRaD sequence (Introduction, Methods, Results, Discussion) with explicit subsections detailing sample recruitment, diagnostic criteria, and statistical analysis plans.
  3. Formatting Declarations and ISAJE Ethical Compliance: Prior to submission, authors must draft comprehensive declaration statements. These include an explicit Declaration of Competing Interests covering financial support from pharmaceutical, alcohol, or gaming corporations; an Ethics Approval statement citing the institutional review board and protocol approval number; a Clinical Trial Registration declaration citing the public registry identifier for interventional studies; and a Data Availability Statement explaining where and how underlying research data can be accessed. Manuscripts disclosing funding from tobacco or e-cigarette manufacturing entities are automatically rejected without review.
  4. ScholarOne Portal Access and Profile Configuration: Submissions are processed entirely through the journal’s web-based peer-review portal at mc.manuscriptcentral.com/addiction. Authors navigate to the portal, log in using their verified credentials or authenticated ORCID iD, and enter the Author Centre dashboard. First-time submitters must populate their profile with institutional affiliations, current academic email addresses, and discipline-specific keywords.
  5. File Upload and Metadata Entry: Within the ScholarOne submission wizard, authors complete the multi-step upload protocol. Required files include the Main Document file (in Microsoft Word or LaTeX format containing the complete text, references, and embedded tables) and individual high-resolution figure files (TIFF or EPS format at 300 DPI minimum resolution). The system prompts authors to input manuscript metadata, including full co-author details, funding grant numbers, and suggested independent peer reviewers.
  6. Editorial Screening and Single-Anonymized Peer Review: Upon submission, the editorial office conducts initial technical and scope triage within 7 to 10 days. Manuscripts meeting baseline criteria are assigned to a Regional Editor and an Associate Editor, who invite two or more expert external referees. Addiction operates a single-anonymized peer-review model where reviewers know author identities but reviewer identities remain confidential. Submissions involving complex clinical trials or advanced econometric models are routinely assigned to a Statistical Review Editor. Authors track real-time progress via their Author Centre dashboard through status designations such as “Awaiting Reviewer Scores”, “Awaiting AE Recommendation”, and “Awaiting Decision”.
  7. Post-Acceptance Production and Wiley Author Services: Following formal acceptance, the production file is transferred to Wiley Production Services. Corresponding authors receive an automated invitation to register on the Wiley Author Services platform. Here, authors complete their digital licensing agreement, selecting between standard copyright transfer (free subscription publishing) or Wiley OnlineOpen (Gold open access under Creative Commons licensing). Authors subsequently download and review electronic page proofs, returning corrections via the Wiley Proofing System within 48 hours to ensure rapid Early View digital publication with an assigned digital object identifier.

Strengths and limits

Evaluating Addiction as a prospective publishing venue or bibliographic information source requires examining both its institutional advantages and its procedural constraints.

Strengths:

  • Unmatched Field Prestige: As one of the oldest and most established journals in behavioral health, publication in Addiction confers substantial academic authority, high citation velocity, and strong visibility among grant review panels and tenure committees.
  • Rigorous Methodological Vetting: The routine deployment of dedicated Statistical and Methodology Review Editors ensures published findings maintain exceptional analytical validity, minimizing questionable research practices and p-hacking.
  • Direct Policy Impact: Articles published in Addiction are systematically tracked and cited by international health organizations, including the World Health Organization, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), and the US National Institute on Drug Abuse (NIDA).
  • Global Inclusivity Initiatives: The journal maintains an active mandate to solicit, mentor, and publish addiction research from low- and middle-income (LAMI) countries, providing dedicated developmental editing support and waivers where appropriate.
  • Comprehensive Open Access Agility: Through Wiley’s extensive global network of transformational read-and-publish agreements (such as Jisc in the UK and Projekt DEAL in Germany), thousands of affiliated authors can publish Gold open access with zero out-of-pocket fees.

Limits:

  • High Selectivity and Desk Rejection Rates: Given its premier positioning, the journal rejects a substantial percentage of unsolicited submissions, often at the initial editorial triage stage without external peer review if incremental novelty is deemed insufficient.
  • Restrictive Word-Count Ceilings: The strict 3,500-word limit for standard Research Reports presents operational challenges for complex multi-site randomized controlled trials, mixed-methods studies, or intricate psychiatric phenotyping, necessitating extensive supplemental online files.
  • Cost Barriers for Uncovered Gold OA: For authors whose home institutions do not maintain transformational agreements with Wiley, standard hybrid open-access Article Processing Charges exceed $4,000 USD, creating barriers for unfunded researchers wishing to publish Gold OA. However, publishing under the traditional subscription model remains entirely free of charge.
  • Translational Human Focus Exclusion: Researchers working strictly on cellular neuroscience, receptor pharmacology, or rodent behavioral models will find the journal’s human-centric editorial focus restrictive, requiring redirection to dedicated basic-science titles.

Alternatives

Authors evaluating where to submit their research can choose among several leading alternative peer-reviewed journals across substance science, pharmacology, and behavioral medicine:

  • Addiction Biology: Also owned by the Society for the Study of Addiction and published by Wiley, Addiction Biology focuses specifically on the genetic, molecular, cellular, neurobiological, and brain-imaging mechanisms of addictive processes. It is the premier alternative for preclinical animal studies and translational human neuroscience.
  • International Journal of Drug Policy (IJDP): Published by Elsevier in affiliation with the International Society for the Study of Drug Policy, IJDP focuses on sociological, legal, political, and harm-reduction aspects of substance use. It is the preferred venue for drug decriminalization analysis, policing reform, and qualitative community health research.
  • Substance Use and Misuse: Published by Taylor and Francis, this journal offers a broad interdisciplinary scope covering public health, social pharmacology, treatment evaluation, and clinical counseling across diverse international settings.
  • Drug and Alcohol Dependence: Published by Elsevier on behalf of the College on Problems of Drug Dependence (CPDD), this journal publishes high-frequency, wide-ranging empirical studies spanning preclinical pharmacology, clinical trials, and epidemiological surveys.
  • Psychology of Addictive Behaviors: Published by the American Psychological Association (APA), this publication specializes in psychological models of craving, cognitive mechanisms, behavioral reinforcement, and psychotherapy outcome trials for chemical and behavioral addictions.

The decision matrix below summarizes how Addiction compares to these peer publications across key editorial parameters:

Journal Title Publisher Primary Disciplinary Focus Review Model Key Differentiating Feature
Addiction Wiley / SSA Clinical, epidemiological, and policy addiction science Single-anonymized Flagship journal with dedicated statistical review and policy impact
Addiction Biology Wiley / SSA Preclinical neurobiology, genetics, and molecular mechanisms Single-anonymized Premier venue for basic neuroscience and translational laboratory models
International Journal of Drug Policy Elsevier / ISSDP Drug law reform, harm reduction, and sociological policy Single-anonymized Leading forum for structural determinants, policing, and drug policy reform
Substance Use and Misuse Taylor and Francis Community health, social pharmacology, and counseling Single-anonymized High volume, broad multidisciplinary international scope
Drug and Alcohol Dependence Elsevier / CPDD Biomedical, behavioral, and clinical addiction studies Single-anonymized Official journal of CPDD with rapid turnaround and high issue volume
Psychology of Addictive Behaviors American Psychological Association Cognitive, behavioral, and psychological mechanisms Masked review Deep emphasis on psychological theory, psychometrics, and psychotherapy

Frequently asked questions

Who publishes the journal Addiction?

The journal Addiction is published by John Wiley and Sons on behalf of the Society for the Study of Addiction (SSA), a UK-based learned society founded in 1884 that holds ultimate ownership and governance over the publication.

What is the difference between Addiction and Addiction Biology?

While both journals are owned by the Society for the Study of Addiction, Addiction publishes clinical, epidemiological, human experimental, and policy research, whereas Addiction Biology specializes in preclinical neurobiology, genetic mechanisms, molecular pharmacology, and neuroimaging studies.

What manuscript types does Addiction accept?

The journal publishes Research Reports, systematic and narrative Reviews, Short Reports, commissioned and unsolicited Commentaries, and Letters to the Editor.

What is the word limit for research reports in Addiction?

Research Reports in Addiction are normally restricted to a maximum of 3,500 words of text, excluding the structured abstract, tables, figures, references, and online supplementary appendices.

Is Addiction an open-access journal?

Addiction operates as a hybrid open-access journal. Authors may publish under the standard subscription model at no cost, or elect to make their article Gold open access via Wiley OnlineOpen, with fees frequently covered by institutional transformational agreements.

What are the ethical requirements under the Farmington Consensus?

As a founding signatory of the Farmington Consensus established by the International Society of Addiction Journal Editors, Addiction mandates comprehensive conflict of interest disclosures, public clinical trial pre-registration, transparent data access statements, and an outright refusal to publish research funded by the tobacco or vaping industries.

Sources

  • Society for the Study of Addiction (SSA). “Addiction: Aims and Scope, Editorial Board, and Governance.” https://addictionjournal.org (Checked 2026-11-14).
  • National Library of Medicine (NLM). “Addiction (NLM Catalog Record No. 9304118).” https://www.ncbi.nlm.nih.gov/nlmcatalog/9304118 (Checked 2026-11-14).
  • John Wiley and Sons. “Addiction Author Guidelines and Journal Overview.” https://onlinelibrary.wiley.com/journal/13600443 (Checked 2026-11-14).
  • International Society of Addiction Journal Editors (ISAJE). “Ethical Guidelines and the Farmington Consensus.” https://www.isaje.net (Checked 2026-11-14).
  • Clarivate. “Addiction Journal Profile in Web of Science Master Journal List.” https://mjl.clarivate.com (Checked 2026-11-14).

Data: Addiction and Substance Science Journal Comparison

Comparative specifications of leading peer-reviewed addiction and substance-use journals, compiled from National Library of Medicine catalog entries, publisher author guidelines, and society charters.

Period covered: 2026. Coverage: Global.

Addiction and Substance Science Journal Comparison
Journal NamePublisherPublication ModelPrint ISSNElectronic ISSNNLM Title AbbreviationPrimary Submission Portal
AddictionJohn Wiley and Sons / Society for the Study of AddictionHybrid Open Access0965-21401360-0443AddictionScholarOne Manuscripts
Addiction BiologyJohn Wiley and Sons / Society for the Study of AddictionHybrid Open Access1355-62151369-1600Addict BiolScholarOne Manuscripts
International Journal of Drug PolicyElsevier / International Society for the Study of Drug PolicyHybrid Open Access0955-39591873-4758Int J Drug PolicyEditorial Manager
Substance Use and MisuseTaylor and FrancisHybrid Open Access1082-60841532-2491Subst Use MisuseScholarOne Manuscripts
Drug and Alcohol DependenceElsevier / College on Problems of Drug DependenceHybrid Open Access0376-87161879-0046Drug Alcohol DependEditorial Manager

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · free to try

Ask about Addiction Journal: Scope, Metrics, and Submission Guide

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →